| Title : Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil - Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| Author(s) : Ortner M , Stange M , Schneider H , Schroder C , Buerger K , Muller C , Muller-Sarnowski F , Diehl-Schmid J , Forstl H , Grimmer T , Steimer W |
| Ref : Drug Des Devel Ther , 14 :3251 , 2020 |
| Abstract : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| ESTHER : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| PubMedSearch : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| PubMedID: 32848364 |
| Title : Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels - Ortner_2020_Front.Pharmacol_11_691 |
| Author(s) : Ortner M , Stange M , Schneider H , Schroeder C , Buerger K , Muller C , Dorn B , Goldhardt O , Diehl-Schmid J , Forstl H , Steimer W , Grimmer T |
| Ref : Front Pharmacol , 11 :691 , 2020 |
| Abstract : Ortner_2020_Front.Pharmacol_11_691 |
| ESTHER : Ortner_2020_Front.Pharmacol_11_691 |
| PubMedSearch : Ortner_2020_Front.Pharmacol_11_691 |
| PubMedID: 32508640 |
| Title : EFNS-ENS\/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease - Schmidt_2015_Eur.J.Neurol_22_889 |
| Author(s) : Schmidt R , Hofer E , Bouwman FH , Buerger K , Cordonnier C , Fladby T , Galimberti D , Georges J , Heneka MT , Hort J , Laczo J , Molinuevo JL , O'Brien JT , Religa D , Scheltens P , Schott JM , Sorbi S |
| Ref : Eur Journal of Neurology , 22 :889 , 2015 |
| Abstract : Schmidt_2015_Eur.J.Neurol_22_889 |
| ESTHER : Schmidt_2015_Eur.J.Neurol_22_889 |
| PubMedSearch : Schmidt_2015_Eur.J.Neurol_22_889 |
| PubMedID: 25808982 |